| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel
1 company
Christine Ring is Chief Legal Officer at NRIX. Christine Ring's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $396K at current prices.
Our model assigns Christine Ring a strong insider score of 75/100, based on 59 past trades. Over a 12-month horizon, 86.0% of those trades were profitable, with an average 12-month return of +27.5%.
The NRIX filings lean toward selling, a net 304,318 shares.
Christine Ring has 70 Form 4 filings on record from February 2021 to October 2026, all as Chief Legal Officer at Nurix Therapeutics (NRIX), 2021–2026.
The 182 reported transactions were 90 option exercises, 80 open-market sales and 12 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 63 sales worth about $6.2M.
The largest open-market sale was 37,600 shares of NRIX at an average $17.07 on November 24, 2025, about $642K.
29 of the 44 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 15 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 3,957 | $26.28 | $103,986.40 | -20.5% | - | - | |
| Oct 2, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE10b5-1 | 5,786 | $23.19 | $134,148.99 | -38.8% | - | - | |
| Sep 2, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE10b5-1 | 5,787 | $25.76 | $149,072.35 | -38.8% | - | - | |
| Aug 3, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE10b5-1 | 16,589 | $23.05 | $382,358.20 | -64.6% | +16.8% | - | |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 3,847 | $23.38 | $89,953.63 | -16.2% | +15.6% | - | |
| Jul 2, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE10b5-1 | 11,008 | $23.56 | $259,366.09 | -44.8% | -1.1% | - | |
| Jun 25, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE10b5-1 | 28,935 | $20.06 | $580,505.54 | -68.1% | +6.3% | - | |
| Jun 2, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE10b5-1 | 8,148 | $16.60 | $135,252.73 | -37.5% | +57.5% | - | |
| May 4, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sell10b5-1 | 8,148 | $16.96 | $138,209.64 | -30.8% | +37.2% | - | |
| May 1, 2026 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sell10b5-1 | 5,394 | $16.76 | $90,406.68 | -16.9% | +40.3% | - |